Select region

Our commitment to the transplant industry

Paragonix Technologies is a leading developer, manufacturer, and service provider in the organ transplant industry, establishing a novel approach to preservation that represents a significant improvement over the traditional standard of care.

Paragonix Advanced Organ Preservation devices combine clinically-proven, stable cooling techniques with digital tracking and monitoring technologies to provide clinicians complete control and oversight throughout the donor organ journey. The clinical impact of Paragonix preservation technology is reinforced by the GUARDIAN clinical registries, the largest database of organ preservation data in the world that analyzes post-transplant outcomes in transplant recipients.

Currently, Paragonix offers six FDA-cleared and five CE-marked preservation devices: the Paragonix SherpaPak® Cardiac Transport System, the LUNGguard® Donor Lung Preservation System, the LIVERguard® Donor Liver Preservation System, the BAROguard® Donor Lung Preservation System, the PancreasPak® Organ Preservation System, and the KidneyVault® Portable Renal Perfusion System. Transplant centers that utilize Paragonix devices have access to a comprehensive, 24/7 national support system composed of experienced transplant clinicians.

When no two transplant journeys are ever the same, controlling every variable becomes a challenge. With a comprehensive approach designed to be there at every step, we are ready for anything.

Advanced Organ Preservation Technology

Each device maintains a consistent thermal environment designed to prevent exposing donor organs to freezing temperatures.

Digital Monitoring & Tracking

The Paragonix App offers a central platform to allow transplant teams to coordinate and manage a procurement with confidence.

Expansive, Clinical Research

The GUARDIAN Registries represent the largest observational database that studies the post-transplant impact of organ preservation.

Clinical Support Services

On-call procurement or support services customized to fit the specific needs of each transplant center with 24-hour availability.

Getinge + Paragonix

A stronger portfolio for the global transplant market

Getinge’s acquisition of Paragonix brings together complementary strengths—pairing Paragonix’s organ preservation technologies, digital solutions, and services with Getinge’s global commercial infrastructure and expertise in acute heart and lung support, digital technologies, and services.

Why it matters

Global expansion of advanced organ preservation and transplant logistics

The acquisition enables Paragonix technologies to scale globally through Getinge’s established international commercial and service infrastructure, extending access beyond the U.S. market.

A more complete transplant care portfolio across the organ journey

Paragonix’s preservation, transport, digital tracking, and services complement Getinge’s strengths in acute care, heart and lung support, and digital technologies—creating broader workflow coverage.

Accelerating innovation in organ transplantation technology

By combining complementary capabilities, Getinge and Paragonix create new opportunities to develop next-generation solutions for preservation, transportation, and transplant-related care.

Positioned for growth in a rapidly evolving transplant market

As transplantation continues to move away from traditional ice storage toward advanced, data-enabled preservation approaches, the combined portfolio is well aligned with market demand.

Strengthening clinical evidence, services, and long-term support

Paragonix’s research initiatives, clinical registries, and service model are reinforced by Getinge’s scale and operational expertise, supporting transplant programs with both technology and infrastructure.